FdaApplication
ANDA 203628
Identifiers
- fda_app_no: ANDA203628
Properties
| Property | Value |
|---|---|
| applicant_name | PHARMOBEDIENT CONSULTING LLC |
| application_type | ANDA |
| approval_date | 2023-03-10 |
Products (1)
| Product | Active ingredient | Strength | Dosage form |
|---|---|---|---|
| PEMETREXED DISODIUM | PEMETREXED DISODIUM | EQ 500MG BASE/VIAL | POWDER;INTRAVENOUS |
1 product